Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Sodium Pentaborate Pentahydrate in Overweight and Obesity
NCT05741606Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2024
- Primary completion
- Jan 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of sodium pentaborate pentahydrate in obesity, sponsored by Tabriz University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
sodium pentaborate pentahydrate
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05741606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05741606.